Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy. Mediterr J Hematol Infect Dis [Internet]. 2021 Jun. 28 [cited 2026 May 27];13(1):e2021042. Available from: https://www.mjhid.org/mjhid/article/view/4613